Cell and Gene Therapies

All the posts published.

The Way Ahead for Cell and Gene Therapies: How to Create Healthcare System Infrastructure that Supports New Pathways to Access and Reimbursement

February 16, 2024
-
Market Access News, Publications
-
Posted by MORSE
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
Read More →

Unlocking the Future of Pharmaceutical Market Access: MORSE Consulting and Medlior Health Outcomes Research Join Forces 

September 14, 2023
-
Market Access News, What's New
-
Posted by MORSE
September 14, 2023 - We are thrilled to announce a groundbreaking collaboration between MORSE Consulting and Medlior Health Outcomes Research, two leaders in the Canadian pharmaceutical market access landscape. This partnership aims to blend MORSE Consulting's unparalleled expertise in payer and HTA strategies with Medlior's cutting-edge real-world evidence solutions, offering our clients an unmatched array of services to navigate the complex world of pharmaceutical market access. MORSE Consulting is a…
Read More →
Cell and Gene Therapies | MORSE Consulting Inc.
Learn More
Learn More